Possible role of D-serine in the pathophysiology of Alzheimer's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 2, 2004, Pages 385-388

  Hashimoto, Kenji ^a   Fukushima, Takeshi ^b   Shimizu, Eiji ^a   Okada, Shin Ichi ^a   Komatsu, Naoya ^a   Okamura, Naoe ^a   Koike, Kaori ^a   Koizumi, Hiroki ^a   Kumakiri, Chikara ^a   Imai, Kazuhiro ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alzheimer's disease; D amino acids; D serine; L serine; NMDA receptor; Serine racemases

Indexed keywords

SERINE;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

EID: 9144232858     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2003.11.009     Document Type: Article

References (21)

1. Andersen J.M., Fonnum F., Myhrer T. D-Serine alleviates retrograde amnesia of a visual discrimination task in rats with a lesion of the perirhinal cortex. Brain Res. 979:2003;240-244.
2. Fisher G., Lorenzo N., Abe H., Fujita E., Frey W.H., Emory C., Di Fiore M.M., D'Aniello A. Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects. Amino Acids. 15:1998;263-269.
3. Hashimoto A., Oka T. Free D-aspartate and D-serine in the mammalian brain and periphery. Prog. Neurobiol. 52:1997;325-353.
4. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S., Hasegawa H., Imai K., Iyo M. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the NMDA receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry. 60:2003;572-576.
5. Imai K., Fukushima T., Santa T., Homma H., Hamase K., Sakai K., Kato M. Analytical chemistry and biochemistry of D-amino acids. Biomed. Chromatogr. 10:1996;303-312.
6. Kornhuber J., Weller M. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neurodegenerative pharmacotherapy. Biol. Psychiatry. 41:1997;135-144.
7. 3H]TCP binding in Alzheimer's disease. Neurosci. Lett. 74:1987;371-376.
8. Molina J.A., Jimenez-Jimenez F.J., Vargas C., Gomez P., de Bustos F., Orti-Pareja M., Tallon-Barranco A., Benito-Leon J., Arenas J., Enriquez-de-Salamanca R. Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease. J. Neural Transm. 105:1998;279-286.
9. Loftis J.M., Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol. Ther. 97:2003;55-85.
10. McKharnn G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
11. Nagata Y., Borghi M., Fisher G.H., D'Aniello A. Free D-serine concentration in normal and Alzheimer human brain. Brain Res. Bull. 38:1995;181-183.
12. Newcomer J.W., Krystal J.H. NMDA receptor regulation of memory and behavior in humans. Hippocampus. 11:2001;529-542.
13. Olney J.W., Wozniak D.F., Farber N.B. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch. Neurol. 54:1997;1234-1240.
14. 3H]MK-801 binding in Alzheimer's disease. J. Neurochem. 53:1989;698-704.
15. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H.J. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med. 348:2003;1333-1341.
16. Schwartz B.L., Hashtroudi S., Herting R.L., Schwartz P., Deutsch S.I. D-Cycloserine enhances implicit memory in Alzheimer patients. Neurology. 46:1996;420-424.
17. Snyder S.H., Ferris C.D. Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatr. 157:2000;1738-1751.
18. Snyder S.H., Kim P.M. D-amino acids as putative neurotransmitters: focus on D-serine. Neurochem. Res. 25:2000;553-560.
19. Sze C., Bi H., Kleinschmidt-DeMasters B.K., Filley C.M., Martin L.J. N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J. Neurol. Sci. 182:2001;151-159.
20. Tsai G., Falk W.E., Gunther J., Coyle J.T. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am. J. Psychiatr. 156:1999;467-469.
21. Wolosker H., Panizzutti R., De Miranda J. Neurobiology through the looking-glass: D-serine as new glial-derived transmitter. Neurochem. Int. 41:2002;327-332.